Navigation Links
Medicare to consider public opinion about medical maggots
Date:4/21/2008

At its upcoming Public Meeting on April 22, 2008, the Centers for Medicare and Medicaid Services (CMS) will solicit public input for the establishment of a Healthcare Common Procedure Coding System (HCPCS) for medicinal maggots.

Level II of the HCPCS is a standardized coding system that is used to identify products, supplies, and services not included in the Current Procedural Terminology (CPT) coding system assigned by the American Medical Association to describe most procedures. Together, CPT codes and HCPCS codes are the mechanism by which most procedures and medical products in this country are listed on insurance claim forms and subsequently reimbursed.

Medical grade maggots have been used in this country for almost 80 years, but it was not until 2003 that they began to be regulated by the Food and Drug Administration (FDA). In January, 2004, Medical Maggots became the first living organism to receive marketing clearance by the FDA as a prescription medical device. Based on efficacy and safety studies, Medical Maggots can be marketed for the treatment of non-healing necrotic wounds, such as pressure ulcers, most diabetic foot ulcers, chronic leg ulcers and traumatic wounds.

A treatment supply of medicinal maggots costs less than $100, but reportedly can save thousands or even tens of thousands of dollars in medical, surgical and hospital costs. Yet, CMS still has not provided the health care industry with a reimbursement code for this critical wound care product.

The AMA considered a CPT code for maggot therapy 3 years ago and again last month. Their decision remains unchanged: clinicians should be reimbursed for their time doing maggot therapy by using standard wound care procedure reimbursement (CPT) codes that already exist. Reimbursement for the additional cost of the maggots, they said, should be obtained by using a designated HCPCS code, to be assigned by CMS.

The purpose of the upcoming Public Meeting is to obtain industry and public reaction to CMS preliminary coding recommendations. According to the published meeting agenda, CMS officials plan to recommend that medicinal maggots not be given a reimbursement code because "No insurer (i.e., Medicare, Medicaid, Private Insurance Sector) identified a national program operating need to establish a HCPCS Level II code to identify Medical Maggots (http://www.cms.hhs.gov/MedHCPCSGenInfo/Downloads/SO-April22_2008.pdf).

Members of the BioTherapeutics, Education and Research (BTER) Foundation disagree with the CMS recommendation, and plan to demonstrate that beneficiaries, health care professionals and taxpayers do see a need for patients and their doctors to be able to use, code, and be reimbursed for using medicinal maggots. According to the charitys director, Dr. Ronald Sherman, BTER Foundation representatives will remind CMS officials that the same efficacy and safety studies that FDA evaluated before clearing Medical Maggots for marketing in the U.S. also demonstrated lower medical costs and high rates of limb salvage. In fact, when used on patients who failed all other medical and surgical treatments for their gangrenous wounds were offered only amputation or maggot therapy, 40-50% of patients who chose maggot therapy healed their wounds and saved their limbs. BTER Foundation members also will present study data that shows that many doctors will not prescribe maggot therapy when their insurance companies do not, or are perceived not to reimburse for the maggots. Not having a reimbursement code for medicinal maggots is like not allowing maggots on the formulary of any insurance company, he says. This is not what we would expect from Medicare, as the leading proponent of high-quality, equitable, cost-efficient medical care.

BTER Foundation Board member Pam Mitchell will also defend maggots at the hearing. She recently published her own experience in which she attributes medicinal maggots as saving her legs and her life (Maggots, Miracles Me, published 2007 by Xulon Press). Until a HCPCS code is established for medicinal maggots, she says, maggot therapy may remain more available for the wealthy who can pay one or two hundred dollars out of pocket rather than the majority of Americans, whether they have medical insurance or not. It seems like it is often easier to get your legs chopped off, and insurance will even pay for it, but not maggot therapy, even though maggot therapy could save your legs and a lot of money, too.


'/>"/>

Contact: Pam Mitchell
info@BTERFoundation.org
949-278-9756
BioTherapeutics, Education & Research Foundation
Source:Eurekalert  

Related medicine news :

1. Avalere Health Data Finds Four-Tier System Growing Among Medicare Part D Plans
2. Study details cost-effectiveness of rheumatoid arthritis treatments for Medicare recipients
3. RF Technologies Assists Healthcare Providers in Avoiding Preventable Injury Conditions to be Denied Reimbursement by Medicare
4. New Legislation Would Expedite Medicare Patient Access to Physical Therapy
5. New Medicare Equipment Bidding Program for Riverside, California Area is Rife with Errors, Says the American Association for Homecare
6. Medicare Bidding Program for Charlotte, N.C. is Plagued by Errors, Says American Association for Homecare
7. Medicare Bidding Program for Dallas, Texas is Rife with Errors, Says American Association for Homecare
8. ACP reports on how scheduled Medicare pay cuts will affect patients
9. Did Medicare Reimbursement Changes Affect Prostate Cancer Treatment?
10. Medicare Bidding Program in Kansas City is Plagued by Problems, Says American Association for Homecare
11. Errors Plague Medicare Competitive Bidding Program in Ohio, Says American Association for Homecare
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Medicare to consider public opinion about medical maggots
(Date:6/25/2016)... ... ... of Bruton Memorial Library on June 21 due to a possible lice infestation, as reported ... head lice: the parasite’s ability to live away from a human host, and to infest ... in the event that lice have simply gotten out of control. , As lice are ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, ... Bronze Wellness at Work award to iHire in recognition of their exemplary accomplishments in ... the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. Her ... would lash out at his family verbally and physically. , “When something upset him, he ... he would use it. He would throw rocks at my other children and say he ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and ... that call for a minimum wage raise to $12 an hour by 2020 and then ... will restore the lost value of the minimum wage, assure the wage floor does not ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... feeding the Frederick area economy by obtaining investment capital for emerging technology companies. ... 2½ years that have already resulted in more than a million dollars of ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 2016   Pulmatrix, Inc ., (NASDAQ: ... drugs, announced today that it was added to the ... its comprehensive set of U.S. and global equity indexes ... important milestone for Pulmatrix," said Chief Executive Officer ... our progress in developing drugs for crucial unmet medical ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, ... less invasive and more durable cerebrospinal fluid treatments, ... funding.  The Series-A funding is led by Innova ... Fund, and other private investors.  Arkis, new financing ... instrumentation and the market release of its in-licensed ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... - Forecast to 2022" report to their offering. ... for the patients with kidney failure, it replaces the function ... the patient,s blood and thus the treatment helps to keep ... in balance. Increasing number of ESRD patients ...
Breaking Medicine Technology: